Get in touch

From R&D to Commercial Manufacturing: How Pharmaceutical Scale-Up Works

Introduction

A pharmaceutical formulation may begin with a relatively small experiment in an R&D laboratory, but successfully manufacturing the same product at commercial scale is a much larger scientific and operational challenge.

Increasing the batch size is only one part of the process.

Equipment changes, material behavior, mixing conditions, processing times, environmental controls, analytical methods and manufacturing parameters can all influence how a formulation performs as production moves from the laboratory to a larger manufacturing environment.

This is why formulation development and scale-up are closely connected.

An effective scale-up strategy helps pharmaceutical companies translate laboratory knowledge into a reproducible commercial manufacturing process while maintaining the intended product quality.

For pharmaceutical and biotechnology companies, working with a CDMO that combines pharmaceutical R&D services in India, process development, analytical capabilities, technology transfer and commercial manufacturing can create continuity throughout this journey.

This article explains how pharmaceutical scale-up works, the stages involved, and what companies should consider when moving a product from development toward commercial manufacturing.

What Is Pharmaceutical Formulation Development?

Pharmaceutical formulation development is the process of designing a dosage form that can deliver the active pharmaceutical ingredient in an appropriate and manufacturable form.

Depending on the product, formulation scientists may evaluate factors such as:

The objective is not simply to create a formulation that works in the laboratory.

The formulation also needs to be suitable for subsequent development, scale-up and manufacturing.

This makes commercial manufacturability an important consideration from the early stages of pharmaceutical R&D.

What Is Scale-Up in Pharmaceutical Manufacturing?

Pharmaceutical scale-up is the structured transition of a manufacturing process from smaller development batches toward larger production volumes.

A typical journey can involve:

Laboratory Development → Development Batches → Pilot Scale → Technology Transfer → Process Validation → Commercial Manufacturing

At each stage, scientists and manufacturing teams build greater understanding of how the product behaves under different manufacturing conditions.

The objective is to establish a process capable of producing the required product consistently at the intended manufacturing scale.

Why Can’t a Laboratory Process Simply Be Made Bigger?

A common misconception is that pharmaceutical scale-up involves multiplying every laboratory ingredient and process parameter by the same factor.

In practice, the relationship is much more complex.

A process that performs successfully in a small laboratory environment may behave differently when transferred to larger manufacturing equipment.

For example, changes can occur in:

The manufacturing equipment itself may also operate differently from the laboratory equipment used during development.

Scale-up therefore requires scientific evaluation rather than simple mathematical multiplication.

The Connection Between Formulation Development and Scale-Up

Strong pharmaceutical formulation development considers future manufacturing requirements from an early stage.

Development scientists need to understand how formulation choices could influence manufacturing.

For example, excipient selection can affect:

Similarly, process choices made during development can influence the equipment and operating parameters required during scale-up.

When development and manufacturing teams collaborate early, potential scale-up considerations can be identified before the product reaches commercial manufacturing.

Stage 1: Pre-Formulation and Product Understanding

The scale-up journey begins with understanding the product.

Development teams study the physical, chemical and pharmaceutical characteristics of the active ingredient and proposed formulation.

This knowledge supports decisions around:

A strong understanding of the product creates the scientific foundation for subsequent formulation and manufacturing activities.

Stage 2: Formulation Development

Once the product characteristics are understood, scientists develop and optimize the formulation.

Multiple formulations or processing approaches may be evaluated before an appropriate development pathway is selected.

The formulation development stage can involve assessing:

For companies working with an experienced pharmaceutical R&D services provider in India, formulation development can also be aligned with future scale-up requirements.

Stage 3: Pharmaceutical Process Development

Once a formulation has been established, the manufacturing process needs to be developed and understood.

Pharmaceutical process development focuses on determining how the product should be manufactured consistently.

Scientists may evaluate variables such as:

The exact variables depend on the dosage form and manufacturing process.

Understanding these variables helps establish a more robust process before larger-scale production begins.

Stage 4: Analytical Development

Analytical methods support pharmaceutical development by providing information about the quality and characteristics of the product.

Depending on the formulation, analytical activities may include methods for assessing:

These analytical methods need to remain suitable as the product moves from R&D into manufacturing.

This makes analytical development an important part of both formulation development and technology transfer.

Stage 5: Pilot-Scale Manufacturing

Pilot-scale manufacturing provides an important bridge between laboratory development and commercial production.

At this stage, the process is performed at a larger scale using equipment and manufacturing conditions that help provide greater insight into future production.

Pilot batches can help teams understand:

The information generated during this stage can then be used to refine the manufacturing process.

Stage 6: Technology Transfer

Once development knowledge has been established, it needs to be transferred into the manufacturing environment.

This process is known as pharmaceutical technology transfer.

Technology transfer can include:

The objective is to ensure that the receiving manufacturing team understands both what needs to be done and the scientific reasoning behind the process.

For this reason, technology transfer services in India can play a central role in moving pharmaceutical products from development toward commercialization.

Why Technology Transfer Is More Than Documentation

Documents are essential, but successful technology transfer also depends on communication between scientific and manufacturing teams.

Development scientists understand how the formulation was created and why certain parameters were selected.

Manufacturing specialists understand the equipment and operational environment in which the process will run.

Bringing these teams together helps translate development knowledge into practical commercial manufacturing.

An integrated CDMO model can make this interaction easier because development and manufacturing capabilities exist within the same organization.

Stage 7: Commercial-Scale Process Optimization

As production moves to larger equipment, certain process parameters may need to be evaluated and optimized.

The objective is not to change the product unnecessarily but to ensure that the process performs appropriately at the intended manufacturing scale.

Manufacturing teams may review:

The resulting process should support consistent and repeatable production.

Stage 8: Process Validation

Before routine commercial manufacturing, pharmaceutical processes undergo appropriate validation activities.

Process validation helps demonstrate that the manufacturing process can operate consistently within established parameters and produce the intended product.

Validation is supported by areas such as:

For pharmaceutical companies, validation represents an important transition toward routine commercial production.

Scale-Up for Oral Solid Dosage Forms

Oral solid dosage forms such as tablets and capsules have their own scale-up considerations.

Depending on the process, scale-up can involve:

Material characteristics can influence how each stage performs when batch sizes increase.

Manufacturing experience is therefore important when transferring oral solid formulations from development to commercial production.

Scale-Up for Sterile Injectables

Sterile injectable products introduce a different set of manufacturing requirements.

Development and scale-up can involve areas such as:

Because sterility must be maintained throughout relevant manufacturing operations, the transition from development to production requires careful coordination.

An experienced sterile injectable CDMO can connect formulation development, analytical activities, technology transfer and sterile commercial manufacturing within one development pathway.

Scale-Up for Oncology and High-Potency Products

Scale-up can become even more specialized for oncology and high-potency medicines.

In addition to pharmaceutical process considerations, manufacturing teams may need to account for containment and controlled material handling.

This means scale-up planning can involve both:

Product/process requirements + manufacturing containment requirements

For an oncology drug development company or pharmaceutical company working with potent compounds, selecting a CDMO with relevant oncology and high-potency manufacturing experience can help maintain continuity as the product moves toward larger-scale production.

Common Pharmaceutical Scale-Up Challenges

Several factors can influence scale-up success.

Equipment Differences

Laboratory and commercial equipment can operate differently even when they perform similar functions.

Material Behavior

Powders, liquids and other materials may behave differently at larger volumes.

Process Parameters

Mixing, drying, filtration or filling conditions may need appropriate evaluation during scale-up.

Analytical Transfer

Testing methods need to transition effectively alongside the manufacturing process.

Cross-Functional Coordination

R&D, manufacturing, analytical, quality and regulatory teams need to remain aligned throughout the project.

A structured scale-up program helps manage these variables systematically.

Why Integrated CDMO Services Matter

Traditionally, pharmaceutical companies could work with separate organizations for formulation development, analytical testing, technology transfer and commercial manufacturing.

This approach can require multiple handovers.

An integrated CDMO services in India model creates a more connected pathway:

R&D → Formulation → Analytical Development → Process Development → Technology Transfer → Scale-Up → Commercial Manufacturing

Keeping these capabilities connected can help preserve product knowledge throughout development.

For complex products, continuity can be particularly valuable because manufacturing teams gain access to the scientific understanding developed earlier in the project.

What to Look for in a Pharmaceutical Scale-Up Partner

Pharmaceutical companies evaluating a development and manufacturing partner should consider several capabilities.

R&D Expertise

Can the organization support formulation and process development?

Analytical Capabilities

Are analytical development and stability activities available?

Technology Transfer

Can development knowledge be systematically transferred into manufacturing?

Manufacturing Infrastructure

Does the organization have equipment appropriate for the intended dosage form?

Therapeutic Expertise

Does the partner understand specialized products such as oncology or high-potency medicines?

Sterile Capabilities

For injectable products, can the organization support sterile manufacturing and relevant processing requirements?

Commercial Manufacturing

Can the partner continue supporting the product after development and scale-up?

A partner capable of supporting the complete pathway can provide continuity as project requirements evolve.

Teyro’s R&D-to-Commercial Manufacturing Approach

Teyro combines pharmaceutical development and manufacturing capabilities within a specialty CDMO platform.

Its capabilities span:

This integrated structure allows pharmaceutical development knowledge to remain connected with manufacturing as a product progresses toward commercialization.

Teyro’s specialization in oncology and high-potency products also supports development programs where manufacturing complexity extends beyond conventional pharmaceutical production.

From Successful Formulation to Successful Commercial Product

A promising formulation does not automatically become a commercially successful manufacturing process.

The transition requires scientific understanding, process knowledge, suitable equipment, analytical support and manufacturing expertise.

This is why formulation development should be considered together with scale-up from the beginning of the product journey.

When R&D teams understand commercial manufacturing requirements—and manufacturing teams understand the science behind the formulation—the transition can become more structured and connected.

Conclusion

Formulation development and scale-up form the bridge between pharmaceutical innovation and commercial manufacturing.

The process begins with understanding the product, continues through formulation and process development, and progresses through pilot manufacturing, technology transfer, validation and commercial production.

Each stage builds additional knowledge about how the formulation behaves and how it can be manufactured consistently at the required scale.

For pharmaceutical companies, selecting a CDMO that combines R&D, analytical development, technology transfer and commercial manufacturing can create valuable continuity throughout this journey.

With integrated development and manufacturing capabilities across oncology, high-potency products, sterile injectables and oral solid dosage forms, Teyro supports pharmaceutical partners from early development through commercial-scale manufacturing.

Call to Action

Looking for a pharmaceutical R&D, scale-up and commercial manufacturing partner in India?

Teyro provides integrated support across formulation development, analytical development, technology transfer, scale-up, oncology and high-potency manufacturing, sterile injectables, oral solid dosage forms and commercial production.

Connect with Teyro to discuss your pharmaceutical development and scale-up requirements.